Detalhe da pesquisa
1.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
J Am Acad Dermatol
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38653344
2.
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
Acta Derm Venereol
; 104: adv19454, 2024 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38323500
3.
Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: A systematic review in pediatric patients.
Pediatr Dermatol
; 41(1): 34-40, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38018272
4.
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Br J Dermatol
; 189(3): 327-335, 2023 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37177895
5.
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
Acta Derm Venereol
; 103: adv00872, 2023 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36794894
6.
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.
Pediatr Allergy Immunol
; 33(12): e13887, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36564878
7.
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
Acta Derm Venereol
; 102: adv00666, 2022 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35098318
8.
Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
Acta Derm Venereol
; 102: adv00820, 2022 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36420885
9.
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry.
J Am Acad Dermatol
; 84(4): 1000-1009, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32946967
10.
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry.
Acta Derm Venereol
; 101(10): adv00573, 2021 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34396421
11.
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.
Allergy
; 75(1): 116-126, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31593343
12.
Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands.
Acta Derm Venereol
; 99(3): 304-308, 2019 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30521056
13.
Use of oral antidepressants in patients with chronic pruritus: A systematic review.
J Am Acad Dermatol
; 77(6): 1068-1073.e7, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29033248
14.
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.
Allergy
; 75(9): 2376-2379, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32302412
15.
Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin.
J Allergy Clin Immunol
; 139(4): 1368-1371, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27725187
16.
Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
Am J Pathol
; 178(5): 2091-9, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21514424
17.
Psoriasis risk genes of the late cornified envelope-3 group are distinctly expressed compared with genes of other LCE groups.
Am J Pathol
; 178(4): 1470-7, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21435436
18.
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
JAMA Dermatol
; 158(9): 1048-1056, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35947364
19.
Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
J Invest Dermatol
; 140(2): 415-424.e10, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31344386
20.
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis.
Clin Transl Allergy
; 13(1): e12219, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36705510